The Protective Role of Interleukin-10 in Sepsis

  • A. Marchant
  • J. L. Vincent
  • M. Goldman
Part of the Yearbook of Intensive Care and Emergency Medicine 1994 book series (YEARBOOK, volume 1994)

Abstract

It is currently admitted that the production of inflammatory cytokines, such as tumor necrosis factor (TNF) and interleukin-1 (IL-1) plays a central role in the pathogenesis of septic shock [1]. So far, the mechanisms controlling inflammatory cytokine release in vivo are poorly understood. The production of corticosteroids, a potent inhibitor of cytokine release by activated macrophages, could be one mechanism controlling cytokine release during gram-negative sepsis as suggested by the increased sensitivity of adrenalectomized mice to lipopolysaccharide (LPS) toxicity [2]. This chapter will discuss data showing that IL-10, a recently described cytokine inhibiting TNF production by LPS-activated macrophages, is released during murine endotoxemia and protects mice from LPS toxicity. We well also show that IL-10 is produced during human septicemia and septic shock and discuss the possible role of IL-10 as a protective cytokine in this setting.

Keywords

Toxicity Corticosteroid Interferon Glucocorticoid Cyclosporin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Glauser MP, Zanetti G, Baumgartner JD, Cohen J (1991) Septic shock: Pathogenesis. Lancet 338: 732–736PubMedCrossRefGoogle Scholar
  2. 2.
    Zuckerman SH, Shellhaas J, Butler LD (1989) Differential regulation of lipopolysaccharide-induced interleukin-1 and tumor necrosis factor synthesis: Effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 19: 301–305PubMedCrossRefGoogle Scholar
  3. 3.
    Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081–2095PubMedCrossRefGoogle Scholar
  4. 4.
    Fiorentino DF, Zlotnik A, Vieira P, et al (1991) IL-10 acts on the antigen presenting cell to inhibit cytokine production by Thl cells. J Immunol 146: 3444–3451PubMedGoogle Scholar
  5. 5.
    Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815–3822PubMedGoogle Scholar
  6. 6.
    Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin-10. J Exp Med 174: 1549–1555PubMedCrossRefGoogle Scholar
  7. 7.
    de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209–1220CrossRefGoogle Scholar
  8. 8.
    Pradier O, Gérard C, Delvaux A, et al (1993) Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 23: 2700–2703PubMedCrossRefGoogle Scholar
  9. 9.
    Gazzinelli RT, Oswald IP, James SL, Sher A (1992) IL-10 inhibits parasite killing and nitrogen oxide production by IFN-y activated macrophages. J Immunol 148: 1792–1796PubMedGoogle Scholar
  10. 10.
    de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE (1992) Interleukin-10 Curr Opin Immunol 4: 314–320Google Scholar
  11. 11.
    Hsu D, Moore KW, Spits H (1992) Differential effects of IL-4 and IL-10 on IL-2 induced IFN-y synthesis and lymphokine-activated killer activity. Int Immunol 4: 563–569PubMedCrossRefGoogle Scholar
  12. 12.
    Beutler B, Milsark IW, Cerami AC (1985) Passive immunisation against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869–871PubMedCrossRefGoogle Scholar
  13. 13.
    Tracey KJ, Fong Y, Hesse DG, et al (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662–664PubMedCrossRefGoogle Scholar
  14. 14.
    Mathison JC, Wolfson E, Ulevitch RJ (1988) Participation of tumor necrosis factor in the mediation of gram-negative bacterial lipopolysaccharide-induced injury in rabbits. J Cin Invest 81: 1925–1937CrossRefGoogle Scholar
  15. 15.
    Silva AT, Bayston KF, Cohen J (1990) Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock. J Infect Dis 162: 421–427PubMedCrossRefGoogle Scholar
  16. 16.
    Heinzel FP (1990) The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 145: 2920–2924PubMedGoogle Scholar
  17. 17.
    Silva AT, Cohen J (1992) Role of interferon-y in experimental gram-negative sepsis. J Infect Dis 166: 331–335PubMedCrossRefGoogle Scholar
  18. 18.
    Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA (1992) Evidence for IFN-y as a mediator of the lethality of endotoxin and tumor necrosis factor-a. J Immunol 149: 1666–1670PubMedGoogle Scholar
  19. 19.
    Jephthah-Ochola J, Urmson J, Farkas S, Halloran PF (1988) Regulation of MHC expression in vivo: Bacterial lipopolysaccharide induces class I and II MHC products in mouse tissues by a T cell-independent, cyclosporin-sensitive mechanism. J Immunol 141: 792–800PubMedGoogle Scholar
  20. 20.
    Gérard C, Bruyns C, Marchant A, et al (1993) Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177: 547–550PubMedCrossRefGoogle Scholar
  21. 21.
    Marchant A, Bruyns C, Vandenabeele P, et al (1993) Interleukin-10 differentially regulates cytokine production during murine endotoxin shock. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 12 (Abst)Google Scholar
  22. 22.
    Howard M, Muchamuel T, Andrade S, Menon S (1993) Interleukin-10 protects mice from lethal endotoxemia. J Exp Med 177: 1205–1208PubMedCrossRefGoogle Scholar
  23. 23.
    Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA (1990) Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75: 40–47PubMedGoogle Scholar
  24. 24.
    Aderka D, Le J, Vilcek J (1989) IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 143: 3517–3523PubMedGoogle Scholar
  25. 25.
    Sironi M, Munoz C, Pollicino T, et al (1993) Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. Eur J Immunol 23: 2692–2695PubMedCrossRefGoogle Scholar
  26. 26.
    Durez P, Abramowicz D, Gérard C, et al (1993) In vivo induction of Interleukin-10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: Differential modulation by cyclosporin. Am J Exp Med 177: 551–555CrossRefGoogle Scholar
  27. 27.
    Marchant A, Bruyns C, Vandenabeele P, et al (1993) Endogenous IL-10 protects mice against endotoxin shock. IVth International Conference on Endotoxins, Amsterdam, 0 35 (Abst)Google Scholar
  28. 28.
    Gadina M, Bertini R, Mengozzi M, Zandalasini M, Mantovani A, Ghezzi P (1991) Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoidsensitive and glucocorticoid-resistant models of endotoxic shock. J Exp Med 173: 1305–1310PubMedCrossRefGoogle Scholar
  29. 29.
    Schade OF (1990) Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ Shock 31: 171–181PubMedGoogle Scholar
  30. 30.
    Fantuzzi G, Marchant A, Sironi M, et al (1993) Chlorpromazine differentially regulates TNF, IL-6 and IL-10 release during murine endotoxemia. IVth International Conference on Endotoxins, Amsterdam P 30 (Abst)Google Scholar
  31. 31.
    Marchant A, Bruyns C, Abramovicz D, et al (1993) Differential regulation of IL-10, IL-6 and TNF release by pentoxifylline during murine endotoxemia. IVth International Conference on Endotoxins, Amsterdam P 33 (Abst)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • A. Marchant
  • J. L. Vincent
  • M. Goldman

There are no affiliations available

Personalised recommendations